Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis

CNS Neurosci Ther. 2016 Dec;22(12):1019-1022. doi: 10.1111/cns.12652. Epub 2016 Oct 13.

Authors

Markus Kinner¹, Robert Hoepner¹, Peter Klotz¹, Christian Prehn¹, Simon Faissner¹, Anke Salmen^{1

2}, Ralf A Linker³, Ralf Gold¹, Andrew Chan^{1

2}

Affiliations

¹ Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
² Department of Neurology, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Neurology, University of Erlangen, Erlangen, Germany.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Cognition Disorders / etiology*
Cognition Disorders / immunology
Cognition Disorders / therapy*
Disability Evaluation
Female
Humans
Immunosuppressive Agents / therapeutic use
Immunotherapy / methods*
Leukocytes / pathology
Longitudinal Studies
Male
Middle Aged
Mitoxantrone / therapeutic use
Multiple Sclerosis, Chronic Progressive / complications*
Neuropsychological Tests
Psychiatric Status Rating Scales
Retrospective Studies
Young Adult

Substances

Immunosuppressive Agents
Mitoxantrone